Studies of the Active Conformation of a Novel Series of Benzamide Dopamine D2 Agonists
David Wustrow
Journal of Medicinal Chemistry, 1994
View PDFchevron_right
Conformational Analysis of D1 Dopamine Receptor Agonists: Pharmacophore Assessment and Receptor Mapping
Val Watts
Journal of Medicinal Chemistry, 1996
View PDFchevron_right
QSAR modeling on dopamine D2 receptor binding affinity of 6-methoxy benzamides
Tarun Jha
Il Farmaco, 2005
View PDFchevron_right
Conformationally-flexible benzamide analogues as dopamine D 3 and σ 2 receptor ligands
Yunsheng Huang
Bioorganic & Medicinal Chemistry Letters, 2004
View PDFchevron_right
Azaindole derivatives with high affinity for the dopamine D4 receptor: Synthesis, ligand binding studies and comparison of molecular electrostatic potential maps
Harald Hübner
Bioorganic & Medicinal Chemistry Letters, 1999
View PDFchevron_right
A Density Functional Study of the Relationships between Electronic Structure and Dopamine D2 receptor binding affinity of a series of [4-(4-Carboxamidobutyl)]-1-arylpiperazines
Juan Sebastián Gómez-Jeria
Research Journal of Pharmaceutical, Biological and Chemical Sciences
View PDFchevron_right
DOPAMINE D 2 RECEPTOR ANTAGONIST ACTIVITY AND MOLECULAR MODELING OF CERTAIN NEW CYCLOHEXANE DERIVED ARYLCARBOXAMIDES STRUCTURALLY RELATED TO METOCLOPRAMIDE
Aida El-Azzouny
Digest Journal of Nanomaterials and Biostructures
View PDFchevron_right
Structure−Activity Relationships for a Novel Series of Dopamine D2-like Receptor Ligands Based on N-Substituted 3-Aryl-8-azabicyclo[3.2.1]octan-3-ol
Theresa Kopajtic
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners
Tomas de Paulis
Journal of Medicinal Chemistry, 1991
View PDFchevron_right
Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands
Ferran Sanz
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Structural Factors that Distinguish Dopamine D1 and D2 Agonists
Emile Bellott
Journal of Molecular Modeling, 1995
View PDFchevron_right
Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626
Robert Mach, Jinbin Xu
Bioorganic & Medicinal Chemistry, 2010
View PDFchevron_right
Comparative Molecular Field Analysis of Dopamine D4 Receptor Antagonists Including 3-[4-(4-Chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5- a ]pyridine (FAUC 113), 3-[4-(4-Chlorophenyl)piperazin-1-ylmethyl]-1 H -pyrrolo[2,3- b ]pyridine (L-745,870), and Clozapine
Peter Gmeiner
Journal of Medicinal Chemistry, 2001
View PDFchevron_right
Further Definition of the D1 Dopamine Receptor Pharmacophore: Synthesis of trans-6,6a,7,8,9,13b-Hexahydro-5H-benzo[d]naphth[2,1-b]azepines as Rigid Analogues of β-Phenyldopamine
Val Watts
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
Structure−Activity Relationship Studies of 4-[2-(Diphenylmethoxy)ethyl]-1-benzylpiperidine Derivatives and Their N-Analogues: Evaluation of Behavioral Activity of O- and N-Analogues and Their Binding to Monoamine Transporters
aloke dutta
Journal of Medicinal Chemistry, 2001
View PDFchevron_right
DOPAMINE D2 RECEPTOR ANTAGONIST ACTIVITY AND MOLECULAR MODELING OF CERTAIN NEW CYCLOHEXANE DERIVED ARYLCARBOXAMIDES …
Abdel-Sattar S. Hamad Elgazwy
chalcogen.ro
View PDFchevron_right
Synthesis, 3D-QSAR, and Structural Modeling of Benzolactam Derivatives with Binding Affinity for the D2 and D3 Receptors
Ferran Sanz
ChemMedChem, 2010
View PDFchevron_right
Synthesis, in silico, and in vitro studies of novel dopamine D 2 and D 3 receptor ligands
Holger Stark
Archiv der Pharmazie, 2021
View PDFchevron_right
Synthesis, in silico, and in vitro studies of novel dopamine D2and D3receptor ligands
Katarina Nikolic
Archiv Der Pharmazie, 2021
View PDFchevron_right
Certain 1,4-Disubstituted Aromatic Piperidines and Piperazines with Extreme Selectivity for the Dopamine D4 Receptor Interact with a Common Receptor Microdomain
Harel Weinstein
Molecular Pharmacology, 2004
View PDFchevron_right
Investigation of key interactions between the second extracellular loop of dopamine D2 receptor and several hydroxy-N-{[2-(4-phenyl-piperaziny-1-yl)ethyl]phenyl}-nicotinamides
Đurđica Ignjatović
Journal of the Serbian Chemical Society, 2014
View PDFchevron_right
Synthesis, dopamine D 2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1 H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1 H-benzimidazole and their analogs
Goran Roglic
European Journal of Medicinal Chemistry, 2005
View PDFchevron_right
Beyond small-molecule sar: Using the dopamine d3 receptor crystal structure to guide drug design
Thomas M. Keck
2014
View PDFchevron_right